C-reactive protein to albumin ratio (CAR) in predicting surgical site infection (SSI) following instrumented posterior lumbar interbody fusion (PLIF)

May 18, 2022

doi: 10.1111/iwj.13843.

Online ahead of print.

Affiliations

Item in Clipboard

Shaozheng Qu et al.

Int Wound J.

2022.

Abstract

Identification of novel markers would contribute to the individualised risk assessment and development of a risk prediction model. This study aimed to investigate the role of the C-reactive protein to albumin ratio (CAR) in predicting surgical site infection (SSI) following instrumented posterior lumbar interbody fusion (PLIF) of lumbar degenerative diseases. This study enrolled patients who underwent PLIF and instrumentation for treatment of lumbar degenerative diseases between 2015 and 2020. Electronic medical records were inquired for data collection, with follow-up register for identifying SSI cases. The optimal cut-off for CAR was determined by constructing the receiver operator characteristic (ROC) curve. Patients with high- or low-CAR value were compared using the univariate analyses, and the association between CAR and the risk of SSI was investigated using multivariate logistics regression analysis. A total of 905 patients were enrolled, twenty-nine (3.2%) had developed an SSI with 72.4% occurring during index hospitalisation, and 11 (1.2%) had deep and 18 (2.0%) superficial SSIs. An SSI was associated with additional 10.7 days of index total hospital stay (P = .001). The CAR was 0-5.43 (median, 0.05), and the optimal cut-off was 0.09 and area under the curve was 0.720 (P < .001). 336 (37.1%) patients had a CAR ≥0.09 and 22 (6.5%) developed an SSI, with a crude risk of 5.6 relative to those with a low CAR. The multivariate analyses showed CAR ≥0.09 was associated with 8.06-fold increased risk of SSI, together with diabetes (P = .018), while hypertension was identified as a protective factor (OR, 0.34; 95%CI, 0.11-1.00, P = .049). High CAR is found to significantly predict the incident SSI following instrumented PLIF of lumbar degenerative diseases, and can be considered as a useful index in practice only after it is verified by future high-level evidences.

Keywords:

C-reactive protein to albumin ratio; lumbar degenerative disease; posterior lumbar interbody fusion; surgical site infection.

References

REFERENCES

1. Crawford AM, Lightsey HM IV, Xiong GX, et al. Variability and contributions to cost associated with anterior versus posterior approaches to lumbar interbody fusion. Clin Neurol Neurosurg. 2021;206:106688.
1. Qureshi R, Puvanesarajah V, Jain A, Shimer AL, Shen FH, Hassanzadeh H. A comparison of anterior and posterior lumbar interbody fusions: complications, readmissions, discharge dispositions, and costs. Spine (Phila Pa 1976). 2017;42(24):1865-1870.
1. Ahn DK, Park HS, Choi DJ, et al. The difference of surgical site infection according to the methods of lumbar fusion surgery. J Spinal Disord Tech. 2012;25(8):E230-E234.
1. Petilon JM, Glassman SD, Dimar JR, Carreon LY. Clinical outcomes after lumbar fusion complicated by deep wound infection: a case-control study. Spine (Phila Pa 1976). 2012;37(16):1370-1374.
1. Pei H, Wang H, Chen M, Ma L, Liu G, Ding W. Surgical site infection after posterior lumbar interbody fusion and instrumentation in patients with lumbar degenerative disease. Int Wound J. 2021;18(5):608-615.